Home Overview Press Room Blog Publications For Students about us
Search

About Global Governance & Human Biotechnology


Several important international bodies have adopted human biotechnology policies, though most regulation takes place at the national level.

International organizations have taken strong stands to prevent human reproductive cloning and inheritable genetic modification. The Council of Europe's Convention on Human Rights and Biomedicine (1997)—the most authoritative international agreement to date—bans inheritable genetic modification, human reproductive cloning, and research cloning while also regulating other human biotechnologies.

UNESCO, the European Parliament, the Group of Eight industrial nations, the World Health Assembly, and the United Nations have also adopted various prohibitions on human reproductive cloning.



CRISPR Opportunities … For What? And For Whom? by Pete ShanksBiopolitical TimesDecember 4th, 2014Money and deals are flowing into the companies founded on CRISPR technology, which promises to enable the precise editing of genomes.
Deceptive Labeling of a Radical Embryo Construction Techniqueby Stuart A. NewmanThe Huffington PostDecember 1st, 2014The British Parliament appears poised to give the go-ahead to a set of techniques for generating infants which, if implemented, would constitute the first cases of large-scale human genetic engineering.
MPs Vote to Make Sex Selection Abortion Illegalby Georgia GrahamDaily Telegraph [UK]November 4th, 2014MPs vote 181 to 1 for a motion brought forward by a cross-party alliance in an effort to end uncertainty over the law.
U.S. Gene Patents: Patient Care Stymied in Canada, Hospital ClaimsCBC News [Canada]November 3rd, 2014An Ottawa hospital is challenging the legality of gene patents that hamper the ability of doctors to freely screen for potentially deadly genetic diseases without fear of being sued for patent violations.
Open Letter to UK Parliament: Avoid Historic Mistake on Rushing Human Genetic Modificationby Paul KnoepflerKnoepfler Lab Stem Cell BlogNovember 2nd, 2014There are too many unanswered questions and risks that remain to allow it to proceed at this time. In fact, moving forward with it would most likely be a tragic mistake for the UK.
Can Scientists Patent Life? The Question Returns to the Supreme Courtby Michael HiltzikLos Angeles TimesOctober 31st, 2014The thorny and unresolved question of whether life itself can be patented may come again before the U.S. Supreme Court, if it accepts a motion filed by Santa Monica-based Consumer Watchdog.
Africa: Synthetic Biology - Artificial Life Threatens Nature and Societyby Glenn AshtonAllAfricaOctober 30th, 2014Biologists continue to push the boundaries of their ability to alter life on earth in novel and unpredictable ways. The latest version is known as synthetic biology, or "synbio."
What Good is a Scientific Meeting If You Dismiss the Science?by Jessica CussinsBiopolitical TimesOctober 29th, 2014The Science and Technology Committee of the UK Parliament held an evidence hearing last week to examine the science and proposed regulation of so-called “mitochondrial donation,” or “3-person IVF,” but huge swaths of evidence were widely dismissed.
Cloning Whistleblower: Little Changed in S. Koreaby Youkyung LeeAssociated PressOctober 24th, 2014The whistle-blower who exposed breakthrough cloning research as a devastating fake says South Korea is still dominated by the values that allowed science fraudster Hwang Woo-suk to become an almost untouchable national hero.
Human-Subjects Research: The Ethics Squadby Elie DolginNatureOctober 21st, 2014Bioethicists are setting up consultancies for research — but some scientists question whether they are needed.
Displaying 1-10 of 235  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760